Long-acting reversible contraception in adolescents in Sub-Saharan Africa: evidence from demographic and health surveys

References

• ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol. 2011;118:184–196.
   PubMedGoogle Scholar
• Ettarh RR, Kyobutungi C. Physical access to health facilities and contraceptive use in Kenya: evidence from the 2008-2009 Kenya Demographic and Health Survey. Afr J Reprod Health. 2012;16:48–56.
   PubMedGoogle Scholar
• Jacobstein R, Curtis C, Spieler J, et al. Meeting the need for modern contraception: effective solutions to a pressing global challenge. Int J Gynaecol Obstet. 2013;121:S9–S29.
   PubMed Web of Science ®Google Scholar
• Darroch JE, Singh S. Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys. Lancet. 2013;381:1756–1762.
   PubMed Web of Science ®Google Scholar
• Prata N, Weidert K, Sreenivas A. Meeting the need: youth and family planning in sub-Saharan Africa. Contraception 2013;88:83–90.
   PubMed Web of Science ®Google Scholar
• Mbonye AK, Wamono F. Access to contraception and HIV testing among young women in a peri-urban district of Uganda. Int J Adolesc Med Health. 2012;24:301–306.
   PubMedGoogle Scholar
• McCurdy RJ, Schnatz PF, Weinbaum PJ, et al. Contraceptive use in adolescents in Sub-Saharan Africa: evidence from Demographic and Health Surveys. Conn Med. 2014;78:261–272.
   PubMedGoogle Scholar
• Adekunle AO, Arowojolu AO, Adedimeji AA, et al. Adolescent contraception: survey of attitudes and practice of health professionals. Afr J Med Med Sci. 2000;29:247–252.
   PubMedGoogle Scholar
• The Family Planning Summit for Safer, Healthier and Empowered Futures. Retrieved July 31st, 2018 from: http://ec2-54-210-230-186.compute-1.amazonaws.com/wp-content/uploads/2017/10/FP2020_Summit_Outcome_Document_V10_Clean.pdf.
   Google Scholar
• Hubacher D, Mavranezouli I, McGinn E. Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. Contraception 2008;78:73–78.
   PubMed Web of Science ®Google Scholar
• Ott MA, Pfeiffer EJ, Fortenberry JD. Perceptions of sexual abstinence among high-risk early and middle adolescents. J Adolescent Health. 2006;39:192–198.
   PubMed Web of Science ®Google Scholar
• Brown W, Ahmed S, Roche N, et al. Impact of family planning programs in reducing high-risk births due to younger and older maternal age, short birth intervals, and high parity. Semin Perinatol. 2015;39:338–344.
   PubMed Web of Science ®Google Scholar
• Babalola S, Figueroa ME, Krenn S. Association of mass media communication with contraceptive use in Sub-Saharan Africa: a meta-analysis of demographic and health surveys. J Health Commun. 2017;22:885–895.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Morrison CS, Baeten JM. Rationale and design of a multi-center, open-label, randomized clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). Gates Open Res. 2017;1:17.
   PubMedGoogle Scholar
• Singata-Madliki M, Hofmeyr GJ. d’Hellencourt FCL. Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomized trial. BMJ Open 2017;7:e019205.
   PubMed Web of Science ®Google Scholar
• Measure DHS ICF International. Final Country Reports. Retrieved August 24th 2018, from Measure DHS: https://dhsprogram.com/pubs/pdf/DHSG1/Guide_to_DHS_Statistics_29Oct2012_DHSG1.pdf.
   Google Scholar
• Corsi DJ, Neuman M, Finlay JE, et al. Demographic and health surveys: a profile. Int J Epidemiol. 2012;41:1602–1613.
   PubMed Web of Science ®Google Scholar
• Development Policy and Analysis Division. LDC information. Retrieved August 24th, 2018 from https://www.un.org/development/desa/dpad/least-developed-country-category.html.
   Google Scholar
• Rossier C, Senderowicz L, Soura A. Do Natural Methods Count? Underreporting of natural contraception in urban Burkina Faso. Studies in Family Planning. 2014;45:171–182.
   PubMed Web of Science ®Google Scholar
• Anguzu R, Tweheyo R, Sekandi JN, et al. Knowledge and attitudes towards use of long acting reversible contraceptives among women of reproductive age in Lubaga division, Kampala district, Uganda. BMC Res Notes. 2014;7:153.
   PubMedGoogle Scholar
• Anyanwu M, Alida BWN. Uptake of long-acting reversible contraceptive devices in Western region of The Gambia. Afr Health Sci. 2017;17:409–417.
   PubMed Web of Science ®Google Scholar
• Thanel K, Garfinkel D, Riley C, et al. Leveraging long acting reversible contraceptives to achieve FP2020 commitments in sub-Saharan Africa: The potential of implants. PLoS One. 2018;13:e0195228.
   PubMed Web of Science ®Google Scholar
• United States Agency for International Development. Uptake and Discontinuation of Long-Acting Reversible Contraceptives (LARCs) in Low-Income Countries: DHS Analytical Studies 54. 2015 September. Retrieved from https://dhsprogram.com/pubs/pdf/as54/as54.pdf on July 30th, 2018.
   Google Scholar
• United Nations, Department of Economic and Social Affairs, Population Division (2015). Trends in Contraceptive Use Worldwide 2015 (ST/ESA/SER.A/349).
   Google Scholar
• Steiner RJ, Liddon H, Swartzendruber AL, et al. Long-acting reversible contraception and condom use among female US high school students: Implications for sexually transmitted infection prevention. JAMA Pediatr. 2016;170:428–434.
   PubMed Web of Science ®Google Scholar
• Lemani C, Kamtuwanje N, Phiri B, et al. Effect of family planning interventions on couple years of protection in Malawi. Int J Gynaecol Obstet. 2018;141:37–44.
   PubMed Web of Science ®Google Scholar
• Measure DHS/ICF International. DHS Guide to Statistics: Demographic and Health Surveys Methodology. Calverton, Maryland: ORC Macro, 2006.
   Google Scholar
• STROBE Statement: Checklist of items that should be included in reports of observational studies. Retrieved on August 24th, 2018 from https://www.strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_combined.pdf.
   Google Scholar
• Medical eligibility criteria for contraceptive use. 5th Edition. Department of Reproductive Health, World Health Organization. Available at http://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/. Accessed on August 24th, 2018.
   Google Scholar
• Eke AC, Alabi-Isama L. Long-acting reversible contraception (LARC) use among adolescent females in secondary institutions in Nnewi, Nigeria. J Obstet Gynaecol. 2011;31:164–168.
   PubMedGoogle Scholar
• Nalwadda G, Mirembe F, Byamugisha J, et al. Persistent high fertility in Uganda: young people recount obstacles and enabling factors to use of contraceptives. BMC Public Health. 2010;10:530.
   PubMed Web of Science ®Google Scholar
• Mutihir JT, Ujah IAO, Uduagbamen PFK, et al. Indications for removal of intrauterine contraceptive devices in Jos, north-central Nigeria. Niger J Clin Pract. 2006;9:105–108.
   PubMedGoogle Scholar
• Castle S. Factors influencing young Malians’ reluctance to use hormonal contraceptives. Stud Fam Plann. 2003;34:186–199.
   PubMed Web of Science ®Google Scholar
• 2013 Statement from the Bellagio Group on LARCs: long-acting reversible contraception in the context of full access, full choice. Population Council. Available at https://www.figo.org/sites/default/files/Final%20Bellagio%20Statement%202013.pdf. Accessed on August 24th, 2018.
   Google Scholar